# ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis

**Authors:** Siyavash Joukar, Mohammad Amin Rajizadeh, Mohammad Abbas Bejeshk, Samaneh Sadat Alavi, Fatemeh Bagheri, Mohammad Rami, Kayvan Khoramipour

PMC · DOI: 10.1038/s41598-024-57818-0 · Scientific Reports · 2024-03-26

## TL;DR

High-intensity interval training improves heart health in diabetic rats by reducing inflammation and injury through ATP-releasing channels.

## Contribution

This study shows that HIIT modulates ATP-releasing channels to reduce cardiac complications in T2D.

## Key findings

- HIIT increased Bcl2 and IL-10 protein expression while decreasing IL-1β, Panx1, P2X7R, NLRP1, and BAX in diabetic rat hearts.
- Training improved systolic and diastolic blood pressure, heart rate, and reduced fibrosis and heart lesion scores.
- Modulation of ATP-releasing channels via HIIT reduced inflammation and apoptosis in diabetic hearts.

## Abstract

Type 2 diabetes (T2D) can cause severe cardiac complications at functional, histologic and molecular levels. These pathological complications could be mediated by ATP-releasing channels such as Panx1 and ATP receptors, in particular P2X7. The aim of our study was to investigate the effect of high-intensity interval training (HIIT) on T2D-induced cardiac complications at the functional, histopathological and molecular levels, with a particular focus on ATP-releasing channels. 48 male Wistar rats at the age of 8 weeks were randomly allocated into four groups: control (Con), Diabetes (T2D), Training (TR), and Diabetes + Training (T2D + TR). T2D was induced by a high-fat diet plus a low dose (35 mg/kg) of STZ administration. Rats in the TR and T2D + TR groups underwent an 8-weeks training program involving intervals ranging from 80 to 100% of their maximum running speed (Vmax), with 4–10 intervals per session. Protein expression of Interleukin 1β (IL1β), Interleukin 10 (IL-10), Pannexin 1 (Panx1), P2X7R (purinergic P2X receptor 7), NLRP1 (NLR Family Pyrin Domain Containing 1), BAX, and Bcl2 were measured in the heart tissue. Additionally, we assessed heart function, histopathological changes, as well as insulin resistance using the homeostasis model assessment of insulin resistance (HOMA-IR). In contrast to the T2D group, HIIT led to increased protein expression of Bcl2 and IL-10 in the heart. It also resulted in improvements in systolic and diastolic blood pressures, heart rate, ± dp/dt (maximum and minimum changes in left ventricular pressure), while reducing protein expression of IL-1β, Panx1, P2X7R, NLRP1, and BAX levels in the heart. Furthermore, left ventricular diastolic pressure (LVDP) was reduced (P ≤ 0.05). Moreover, heart lesion scores increased with T2D but decreased with HIIT, along with a reduction in fibrosis percentage (P ≤ 0.05). The results of this study suggest that the cardioprotective effects of HIIT on the diabetic heart may be mediated by the modulation of ATP-releasing channels. This modulation may lead to a reduction in inflammation and apoptosis, improve cardiac function, and attenuate cardiac injury and fibrosis.

## Linked entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553], IL10 (interleukin 10) [NCBI Gene 3586], PANX1 (pannexin 1) [NCBI Gene 24145], P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439], NLRP1 (NLR family pyrin domain containing 1) [NCBI Gene 22861], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596]
- **Proteins:** IL10 (interleukin 10), PANX1 (pannexin 1), P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7), NLRP1 (NLR family pyrin domain containing 1), BAX (BCL2 associated X, apoptosis regulator), BCL2 (BCL2 apoptosis regulator)
- **Diseases:** Type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** Nlrp1a (NLR family, pyrin domain containing 1A) [NCBI Gene 360557] {aka Nalp1, Nlrp1}, Panx1 (Pannexin 1) [NCBI Gene 315435] {aka px1}, Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}
- **Diseases:** fibrosis (MESH:D005355), cardiac complications (MESH:D006331), Diabetes (MESH:D003920), T2D (MESH:D003924), insulin resistance (MESH:D007333), inflammation (MESH:D007249)
- **Chemicals:** STZ (MESH:D013311)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10965991/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10965991/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC10965991/full.md

---
Source: https://tomesphere.com/paper/PMC10965991